Hello, Fool! | Login | Signup | My Fool
Jul 24, 2008 8:59 AM ET | Site Changes | Help
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
View All Commentary (AMLN)
Recs
stratton6 (99.25) Submitted: 8/06/06 5:03 PM : Start Price: $47.41 AMLN Score: -38.27
Demand for exenatide is exdeeding capacity (Partnered with Lilly). Collaboration with Alkermes for extended delivery of this product.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK